Erratum to: A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting – rationale, design and baseline characteristics

• Published in: Current controlled trials in cardiovascular medicine 2009-01, Vol.10 (1), p.7, Article 7
• Main Authors: Laurence, Caroline, Gialamas, Angela, Yelland, Lisa, Bubner, Tanya, Ryan, Philip, Willson, Kristyn, Glastonbury, Briony, Gill, Janice, Shephard, Mark, Beilby, Justin
• Format: Article
• Language: English
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/1745-6215-10-7

Comparison of patient baseline characteristics by condition Condition Group Characteristic Control n (%) Intervention n (%) Total n (%) Diabetes N = 785 N = 1182 N = 1967 Male 432 (55.0) 651 (55.1) 1083 (55.1) Age (years) Median (IQ range) 67.0 (59.0–74.0) 66.0 (58.0–73.0) 66.0 (59.0–73.0) Aboriginal and Torres Strait Islander Yes 4 (0.5) 23 (1.9) 27 (1.4) No 723 (92.1) 1036 (87.6) 1759 (89.4) Missing 58 (7.4) 123 (10.4) 181 (9.2) BMI Underweight 5 (0.6) 3 (0.3) 8 (0.4) Normal 121 (15.4) 181 (15.3) 302 (15.4) Overweight 243 (31.0) 386 (32.7) 629 (32.0) Obese 334 (42.5) 464 (39.3) 798 (40.6) Missing 82 (10.4) 148 (12.5) 230 (11.7) HbA1c % Median (IQ range) 7.1 (6.3–8.0) 6.9 (6.2–7.7) 7.0 (6.3–7.8) Missing 64 (8.2) 90 (7.6) 154 (7.8) Diabetes management: Dietary control Yes 446 (56.8) 604 (51.1) 1050 (53.4) No 309 (39.4) 503 (42.6) 812 (41.3) Missing 30 (3.8) 75 (6.3) 105 (5.3) Insulin Yes 145 (18.5) 204 (17.3) 349 (17.7) No 610 (77.7) 903 (76.4) 1513 (76.9) Missing 30 (3.8) 75 (6.3) 105 (5.3) Prescription tablets Yes 541 (68.9) 729 (61.7) 1270 (64.6) No 214 (27.3) 378 (32.0) 592 (30.1) Missing 30 (3.8) 75 (6.3) 105 (5.3) Years since first diagnosed < 1 year 39 (5.0) 67 (5.7) 106 (5.4) 1–5 years 256 (32.6) 403 (34.1) 659 (33.5) 6–10 years 201 (25.6) 235 (19.9) 436 (22.2) > 10 years 230 (29.3) 311 (26.3) 541 (27.5) Missing 59 (7.5) 166 (14.0) 225 (11.4) Hyperlipidaemia N = 1463 N = 2356 N = 3819 Male 753 (51.5) 1277 (54.2) 2030 (53.2) Age (years) Median (IQ range) 68.0 (60.0–74.0) 66.0 (58.0–74.0) 66.0 (59.0–74.0) Aboriginal and Torres Strait Islander Yes 9 (0.6) 26 (1.1) 35 (0.9) No 1342 (91.7) 2102 (89.2) 3444 (90.2) Missing 112 (7.7) 228 (9.7) 340 (8.9) Index of Relative Socio-Economic Disadvantage 1st quartile 251 (17.2) 575 (24.4) 826 (21.6) 2nd quartile 476 (32.5) 756 (32.1) 1232 (32.3) 3rd quartile 390 (26.7) 663 (28.1) 1053 (27.6) 4th quartile 346 (23.7) 362 (15.4) 708 (18.5) Co-morbid conditions: Known heart disease Yes 540 (36.9) 812 (34.5) 1352 (35.4) No 869 (59.4) 1398 (59.3) 2267 (59.4) Missing 54 (3.7) 146 (6.2) 200 (5.2) Diabetes 509 (34.8) 853 (36.2) 1362 (35.7) Smoking status Current 103 (7.0) 201 (8.5) 304 (8.0) Ex-smoker 644 (44.0) 1001 (42.5) 1645 (43.1) Never smoked 654 (44.7) 990 (42.0) 1644 (43.0) Missing 62 (4.2) 164 (7.0) 226 (5.9) Total cholesterol Median (IQ range) 4.7 (4.0–5.4) 4.6 (4.0–5.4) 4.7 (4.0–5.4) Missing 99 (6.8) 186 (7.9) 285 (7.5) Triglyceride Median (IQ range) 1.6 (1.1–2.2) 1.6 (1.2–2.2) 1.6 (1.2–2.2) Missing 185 (12.6)